<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04798352</url>
  </required_header>
  <id_info>
    <org_study_id>STEINMETZ BOSTON BARD 2019</org_study_id>
    <nct_id>NCT04798352</nct_id>
  </id_info>
  <brief_title>Follow-up Study in French Practice to Evaluate Improvements in Walking and Pain Relief in Patients Treated With Endovascular Treatment of de Novo Lesions of the Femoropopliteal Artery Above the Knee With LUTONIX®035 or RANGER TM Active Ballon</brief_title>
  <acronym>EQUATEUR</acronym>
  <official_title>Follow-up Study in French Practice to Evaluate the Improvement of Gait and Pain Relief in Patients Treated With Endovascular Endovascular Treatment of de Novo Lesions of the Femoropopliteal Artery Above the Knee With LUTONIX®035 or RANGER TM Active Ballon</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Dijon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Dijon</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is part of the subordination for the renewal of the registration of the&#xD;
      LUTONIXR035 or RANGERTM drug coated balloon catheter by the CNEDiMTS following the&#xD;
      transmission of the results of a French study on quality of life (evaluation of pain relief&#xD;
      and walking evaluation criteria) for patients treated for de novo lesions of the&#xD;
      femoropopliteal artery above the knee by endovascular treatment with LUTONIXR035 or RANGERTM&#xD;
      drug-coated balloon catheters.&#xD;
&#xD;
      In accordance with the HAS practical guide on the approval of medical devices in France&#xD;
      (November 2017), the protocol for this study was submitted in advance to the HAS and its&#xD;
      suggestions were taken into account when drafting the objectives relative to the population&#xD;
      to be included.&#xD;
&#xD;
      A second exhaustive study will be conducted in parallel using SNDS data to complete the&#xD;
      CNEDiMTS application in order to evaluate, in the context of this registration renewal, the&#xD;
      interest of the technique by documenting limb preservation, overall survival, the rate of&#xD;
      re-interventions and the number of stents implanted.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 4, 2020</start_date>
  <completion_date type="Anticipated">December 2024</completion_date>
  <primary_completion_date type="Anticipated">December 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>average score of the WIQ specific self-questionnaire</measure>
    <time_frame>at inclusion</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>average score of the WIQ specific self-questionnaire</measure>
    <time_frame>and at 12 months after surgery</time_frame>
    <description>progression of the functional limitations for walking evaluated by the average score of the WIQ specific self-questionnaire 12 months after surgery</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Drug-coated Balloon Catheter</condition>
  <arm_group>
    <arm_group_label>LUTONIX(R)035 drug-coated balloon catheter</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>RANGER TM drug-coated balloon catheter</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>6-minute walk test</intervention_name>
    <description>6-minute walk test</description>
    <arm_group_label>LUTONIX(R)035 drug-coated balloon catheter</arm_group_label>
    <arm_group_label>RANGER TM drug-coated balloon catheter</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>WIQ functional questionnaire</intervention_name>
    <description>WIQ functional questionnaire</description>
    <arm_group_label>LUTONIX(R)035 drug-coated balloon catheter</arm_group_label>
    <arm_group_label>RANGER TM drug-coated balloon catheter</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>quality of life questionnaires (EQ5D5L and SF-36)</intervention_name>
    <description>quality of life questionnaires (EQ5D5L and SF-36)</description>
    <arm_group_label>LUTONIX(R)035 drug-coated balloon catheter</arm_group_label>
    <arm_group_label>RANGER TM drug-coated balloon catheter</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patient having given express oral consent&#xD;
&#xD;
          -  patient to be treated by endovascular procedure with a LUTONIXR035 or RANGER TM drug&#xD;
             coated balloon catheter according to the recommendations of the ANSM dated 13/05/2019&#xD;
             1 and possible updates of these recommendations.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  pregnant or likely to be pregnant (a pregnancy test may be carried out if necessary&#xD;
             according to the centre's practice)&#xD;
&#xD;
          -  adult unable to express consent&#xD;
&#xD;
          -  patient whose follow-up is considered impossible by the investigator (comprehension&#xD;
             problem, planned move, ...)&#xD;
&#xD;
        Per-intervention exclusion criteria&#xD;
&#xD;
          -  patient considered to have failed endovascular treatment (presence of residual&#xD;
             stenosis of more than 30% after surgery despite the possible use of a stent.&#xD;
&#xD;
          -  Patient opéré mais pour lequel le ballon n'a finalement pas été utilisé au cours de&#xD;
             l'intervention&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Chu Dijon Bourgogne</name>
      <address>
        <city>Dijon</city>
        <zip>21000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric STEINMETZ</last_name>
      <phone>03 80 29 33 52</phone>
      <phone_ext>+33</phone_ext>
      <email>eric.steinmetz@chu-dijon.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>March 8, 2021</study_first_submitted>
  <study_first_submitted_qc>March 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 15, 2021</study_first_posted>
  <last_update_submitted>September 28, 2021</last_update_submitted>
  <last_update_submitted_qc>September 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

